UnknownNot Applicable

Natural History of COVID-19-Related Atrial Fibrillation

United States, Belgium, Italy200 participantsStarted 2021-04-15

Plain-language summary

The unCOVer-AF prospective, multicenter registry aims at determining the natural history of atrial fibrillation (AF) via continuous cardiac rhythm monitoring in patients with a first arrhythmic episode during COVID-19 hospitalization.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. implantation of an ILR, a PMK, or an ICD during COVID-19 hospitalization or within 30 days after hospital discharge, or
✓. an ILR, a PMK, or an ICD implanted before COVID-19 hospitalization.

What they're measuring

AF Burden

Timeframe: 3 years

AF Progression

Timeframe: 3 years

Time to adjudicated ischemic stroke/transient ischemic attack (TIA)/systemic arterial embolism

Timeframe: 3 years

Trial details

NCT IDNCT04830774

SponsorTexas Cardiac Arrhythmia Research Foundation

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-31

Contact for this trial

Domenico G Della Rocca, MD

(512) 807-3150 domenicodellarocca@hotmail.it

View on ClinicalTrials.gov More COVID-19 trials